Seborrheic Dermatitis in Neuroleptic-Induced Parkinsonism
Abstract
An increased prevalence of seborrheic dermatitis has previously been noted in idiopathic Parkinson's disease and in postencephalitic parkinsonism. Our study of 42 hospitalized patients with drug-induced parkinsonism and 47 hospitalized psychiatric patients without that disorder showed a statistically significant higher prevalence of clinically diagnosed seborrheic dermatitis in the group with drug-induced parkinsonism (59.5% v 15%). To our knowledge, this is the first report of an increased prevalence of seborrheic dermatitis with drug-induced parkinsonism.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The high incidence of SD in patients with Parkinson's disease and neuroleptic-induced Parkinsonism has long been observed, especially in those with severe seborrhea.
“The high incidence of SD in patients with Parkinson’s disease [17,87,88] and neuroleptic-induced Parkinsonism [89,90] has long been observed, especially in those with severe seborrhea, which provides favorable conditions for Malassezia proliferation.”
From Seborrheic Dermatitis and Dandruff: A Comprehensive Review (2015) · cites this paper as [89]
Cited by
Sorted by citations
Seborrheic Dermatitis and Dandruff: A Comprehensive Review
(2015) · Journal of Clinical and Investigative Dermatology · doi:10.13188/2373-1044.1000019 · Cited by 398 · see citing works
Naldi, L., & Rebora, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0806464 · Cited by 188 · see citing works
- Authors
- Binder, R. L.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 1983-06-01
- Volume
- 119
- Issue
- 6
- Pages
- 473
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2010603981
- Cited by
- 78
- References
- 0
- Citations by year
- 2024: 3 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 2 · 2013: 5 · 2012: 2
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Nail Diseases and Treatments
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- seborrheic dermatitis, drug-induced parkinsonism, antipsychotic drugs, antipsychotic adverse effects, Parkinson's disease, postencephalitic parkinsonism, prevalence, psychiatric patients
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Parkinson Disease, Parkinson Disease, Secondary, Dermatitis, Seborrheic, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
